Cargando…
Cyclodextrins in Parkinson’s Disease
Parkinson’s disease is a movement disorder characterized by a progressive degeneration of dopaminergic neurons that has been object of study by the scientific community through the last decades. However, nowadays there is still no treatment to cure it, although there are drugs available, with limite...
Autores principales: | Barros, Marisa C. F., Ribeiro, Ana C. F., Esteso, Miguel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359444/ https://www.ncbi.nlm.nih.gov/pubmed/30583478 http://dx.doi.org/10.3390/biom9010003 |
Ejemplares similares
-
Cyclodextrins as Drug Release Modulators and Toxic Compound Removal Agents
por: Ribeiro, Ana C. F., et al.
Publicado: (2023) -
Drug Delivery Systems: Study of Inclusion Complex Formation between Methylxanthines and Cyclodextrins and Their Thermodynamic and Transport Properties
por: Santos, Cecília I. A. V., et al.
Publicado: (2019) -
Interactions between Sodium Hyaluronate and β-Cyclodextrin as Seen by Transport Properties
por: Musilová, Lenka, et al.
Publicado: (2023) -
Interactions of Sodium Salicylate with β-Cyclodextrin and an Anionic Resorcin[4]arene: Mutual Diffusion Coefficients and Computational Study
por: Galindres, Diana M., et al.
Publicado: (2023) -
Complexation of 5-Fluorouracil with β-Cyclodextrin and Sodium Dodecyl Sulfate: A Useful Tool for Encapsulating and Removing This Polluting Drug
por: Cabral, Ana M. T. D. P. V., et al.
Publicado: (2022)